Developments within the Market and Industry: Covers notable events like the expansion of the pipeline for oral GLP-1, license agreements by big pharmaceuticals, developments in clinical studies, payer attention, the reimbursement situation, the role of telemedicine in prescribing and increasing preference for non-injectable options
I know, I know before we all lose it
doi:10.1016/j.dmpk.2016.08.005 Nalecz KA, Miecz D, Berezowski V, Cecchelli R (2004) Carnitine: transport and physiological functions in the brain
In alcune categorie di pazienti a rischio, l'uso di L-Carnitina, seppur raramente, potrebbe aumentare la frequenza e la severit di alcuni sintomi psichiatrici, tra i quali ad esempio il senso di agitazione e i disturbi del comportamento
Finally, melatonin decreased HPSC viability in a time and concentration-dependent manner